Eli Lilly Drives Large-Cap Earnings Growth as Valuation Surpasses One Trillion Dollars

New York, Sunday, 8 November 2026.
Surging demand for obesity treatments propelled Eli Lilly past a $1.2 trillion market valuation, leading Wall Street analysts to project robust corporate earnings growth despite broader equity market volatility.